Vicenzetto Cristina, Giordani Andrea Silvio, Menghi Caterina, Baritussio Anna, Scognamiglio Federico, Pontara Elena, Bison Elisa, Peloso-Cattini Maria Grazia, Marcolongo Renzo, Caforio Alida Linda Patrizia
Cardiology, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35128 Padova, Italy.
Cardioimmunology Laboratory, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35128 Padova, Italy.
Cells. 2024 Dec 17;13(24):2082. doi: 10.3390/cells13242082.
Myocarditis is an inflammatory disease of the myocardium with heterogeneous etiology, clinical presentation, and prognosis; when it is associated with myocardial dysfunction, this identifies the entity of inflammatory cardiomyopathy. In the last few decades, the relevance of the immune system in myocarditis onset and progression has become evident, thus having crucial clinical relevance in terms of treatment and prognostic stratification. In fact, the advances in cardiac immunology have led to a better characterization of the cellular subtypes involved in the pathogenesis of inflammatory cardiomyopathy, whether the etiology is infectious or autoimmune/immune-mediated. The difference in the clinical course between spontaneous recovery to acute, subacute, or chronic progression to end-stage heart failure may be explained not only by classical prognostic markers but also through immune-pathological mechanisms at a cellular level. Nevertheless, much still needs to be clarified in terms of immune characterization and molecular mechanisms especially in biopsy-proven myocarditis. The aims of this review are to (1) describe inflammatory cardiomyopathy etiology, especially immune-mediated/autoimmune forms, (2) analyze recent findings on the role of different immune cells subtypes in myocarditis, (3) illustrate the potential clinical relevance of such findings, and (4) highlight the need of further studies in pivotal areas of myocarditis cellular immunology.
心肌炎是一种病因、临床表现和预后各异的心肌炎症性疾病;当它与心肌功能障碍相关时,就确定了炎症性心肌病这一实体。在过去几十年中,免疫系统在心肌炎发病和进展中的相关性已变得明显,因此在治疗和预后分层方面具有至关重要的临床意义。事实上,心脏免疫学的进展使得对参与炎症性心肌病发病机制的细胞亚型有了更好的特征描述,无论其病因是感染性的还是自身免疫性/免疫介导的。从自发恢复到急性、亚急性或慢性进展至终末期心力衰竭的临床病程差异,不仅可以用经典的预后标志物来解释,还可以通过细胞水平的免疫病理机制来解释。然而,在免疫特征和分子机制方面仍有许多需要阐明的地方,尤其是在经活检证实的心肌炎中。本综述的目的是:(1)描述炎症性心肌病的病因,尤其是免疫介导/自身免疫形式;(2)分析不同免疫细胞亚型在心肌炎中作用的最新研究结果;(3)说明这些研究结果的潜在临床相关性;(4)强调在心肌炎细胞免疫学关键领域进行进一步研究的必要性。